Drawing for AACE ENDOCRINE AI

USPTO serial 99976181

AACE ENDOCRINE AI

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
CAYSIDO, REBECCA TOLENTINO
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AACE ENDOCRINE AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard S. Vermut

Richard S. Vermut DRIVER, MCAFEE, HAWTHORNE & DIEBENOW, PLLC1 Independent Drive, Ste 1200Jacksonville, FL 32202United States

Goods and services

ClassDescriptionStatusFirst use
041Providing online training in the field of endocrinology, metabolic care, diabetes, and clinical practices; Providing online training in the field of understanding, evaluating, and using artificial intelligence and related tools in the areas of endocrinology, metabolic care, diabetes, and clinical practices; Providing on-line special reports and webinars in the field of endocrinology, metabolic care, diabetes, and clinical practices; Providing on-line special reports and webinars in the field of understanding, evaluating, and using artificial intelligence and related tools in the areas of endocrinology, metabolic care, diabetes, and clinical practices; Educational services, namely, developing, arranging, and conducting programs in the field of endocrinology, metabolic care, diabetes, and clinical practices; Educational services, namely, developing, arranging, and conducting educational programs in the field of understanding, evaluating, and using artificial intelligence and related tools in the areas of endocrinology, metabolic care, diabetes, and clinical practices; Educational services, namely, conducting programs in the field of endocrinology, metabolic care, diabetes, and clinical practices; Educational services, namely, conducting programs in the field of understanding, evaluating, and using artificial intelligence and related tools in the areas of endocrinology, metabolic care, diabetes, and clinical practices; Providing training in the field of endocrinology, metabolic care, diabetes, and clinical practices; Providing training in the field of understanding, evaluating, and using artificial intelligence and related tools in the areas of endocrinology, metabolic care, diabetes, and clinical practices; Providing continuing medical education courses; Educational services, namely, providing online instruction in the field of endocrinology, metabolic care, diabetes, and clinical practices; Educational services, namely, providing online instruction in the field of understanding, evaluating, and using artificial intelligence and related tools in the areas of endocrinology, metabolic care, diabetes, and clinical practicesACTIVE—
044Providing medical information; Providing medical information via a website; Providing medical information in the field of endocrinology, metabolic care, diabetes, and clinical practices; Providing medical information in the field of understanding, evaluating, and using artificial intelligence and related tools in the areas of endocrinology, metabolic care, diabetes, and clinical practicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 4, 2026EX1GSOU EXTENSION 1 GRANTED—
Nov 4, 2026DPCCDIVISIONAL PROCESSING COMPLETE—
Oct 23, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 17, 2026IUAFUSE AMENDMENT FILED—
Sep 17, 2026EXT1SOU EXTENSION 1 FILED—
Sep 17, 2026DRRRDIVISIONAL REQUEST RECEIVED—
Sep 17, 2026ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 17, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 25, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 30, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 24, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 2, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 2, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jun 2, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 2, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 2, 2026DOCKASSIGNED TO EXAMINER—
Jun 1, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 2, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 2, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance